According to fund sponsor T. Rowe Price, managers invest in four main categories: Pharmaceuticals, health care companies, ...

Federal officials have a plan that could curb billions of dollars in overpayments to Medicare Advantage plans. But will they ...

Proposed Trump administration changes to federal Medicare Advantage payments would stop health insurers from mining patient data for extra medical diagnoses that generate more bills to taxpayers even ...

CMS's proposed 0.09% Medicare Advantage rate hike for 2027 triggered a sharp sell-off across US health insurers, signaling ...

Shield’s FDA-approved blood test drives cancer screening growth, pricing power, and cash-flow upside. Click for this GH ...